JPH01193265A - 新規抗腫瘍性抗生物質ｓｆ２５８７物質及びその製造法 - Google Patents

新規抗腫瘍性抗生物質ｓｆ２５８７物質及びその製造法

Info

Publication number
JPH01193265A
JPH01193265A JP63015983A JP1598388A JPH01193265A JP H01193265 A JPH01193265 A JP H01193265A JP 63015983 A JP63015983 A JP 63015983A JP 1598388 A JP1598388 A JP 1598388A JP H01193265 A JPH01193265 A JP H01193265A
Authority
JP
Japan
Prior art keywords
substance
culture
production
chloroform
antitumor antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP63015983A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0427237B2 (enExample
Inventor
Yoshikazu Sato
佐藤　吉和
Hiromi Watabe
渡部　宏臣
Shigetaka Ishii
石井　成貴
Tadashi Nakazawa
中沢　正
Takashi Shomura
庄村　喬
Masaji Sezaki
瀬崎　正次
Shinichi Kondo
信一 近藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Priority to JP63015983A priority Critical patent/JPH01193265A/ja
Priority to DE68912355T priority patent/DE68912355T2/de
Priority to EP89101481A priority patent/EP0326173B1/en
Priority to US07/303,230 priority patent/US4954641A/en
Publication of JPH01193265A publication Critical patent/JPH01193265A/ja
Publication of JPH0427237B2 publication Critical patent/JPH0427237B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP63015983A 1988-01-28 1988-01-28 新規抗腫瘍性抗生物質ｓｆ２５８７物質及びその製造法 Granted JPH01193265A (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP63015983A JPH01193265A (ja) 1988-01-28 1988-01-28 新規抗腫瘍性抗生物質ｓｆ２５８７物質及びその製造法
DE68912355T DE68912355T2 (de) 1988-01-28 1989-01-27 Antibiotische Antitumor-Verbindung und Methode zu deren Herstellung.
EP89101481A EP0326173B1 (en) 1988-01-28 1989-01-27 Novel antitumor antibiotic substance and a method for production thereof
US07/303,230 US4954641A (en) 1988-01-28 1989-01-30 Novel antitumor antibiotic substance and a method for production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63015983A JPH01193265A (ja) 1988-01-28 1988-01-28 新規抗腫瘍性抗生物質ｓｆ２５８７物質及びその製造法

Publications (2)

Publication Number Publication Date
JPH01193265A true JPH01193265A (ja) 1989-08-03
JPH0427237B2 JPH0427237B2 (enExample) 1992-05-11

Family

ID=11903907

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63015983A Granted JPH01193265A (ja) 1988-01-28 1988-01-28 新規抗腫瘍性抗生物質ｓｆ２５８７物質及びその製造法

Country Status (4)

Country Link
US (1) US4954641A (enExample)
EP (1) EP0326173B1 (enExample)
JP (1) JPH01193265A (enExample)
DE (1) DE68912355T2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102644392A (zh) * 2012-05-07 2012-08-22 张建忠 一种可运输的钢结构密闭单元模块以及制作该单元模块的制造方法
WO2019031880A1 (ko) * 2017-08-10 2019-02-14 가톨릭대학교 산학협력단 키다마이신 유도체 l1-95-1 및 이를 유효성분으로 함유하는 암 예방 또는 치료용 조성물

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1321788C (en) * 1988-09-30 1993-08-31 Masaji Sezaki Antitumor substance, process for preparing the same and anticancer agent containing the same
JPH03148275A (ja) * 1989-11-02 1991-06-25 Meiji Seika Kaisha Ltd Ｓｆ２５８７物質誘導体，その製造法および制癌剤
JP2766351B2 (ja) * 1989-11-13 1998-06-18 協和醗酵工業株式会社 新規物質ｄｃ１１４―ｃ
US5168100A (en) * 1990-03-16 1992-12-01 Sapporo Breweries Limited Hp530 compounds and process for preparing the same
JPH05279374A (ja) * 1992-03-31 1993-10-26 Sawao Murao スイダトレスチン及びその製造方法
CN115650913B (zh) * 2022-10-12 2024-03-01 北京中医药大学 醌式喹啉类化合物及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0819148B2 (ja) * 1986-07-21 1996-02-28 協和醗酵工業株式会社 新規物質ｄｃ―９２ｂ及びｄｃ―９２ｄ

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102644392A (zh) * 2012-05-07 2012-08-22 张建忠 一种可运输的钢结构密闭单元模块以及制作该单元模块的制造方法
WO2019031880A1 (ko) * 2017-08-10 2019-02-14 가톨릭대학교 산학협력단 키다마이신 유도체 l1-95-1 및 이를 유효성분으로 함유하는 암 예방 또는 치료용 조성물

Also Published As

Publication number Publication date
EP0326173A3 (en) 1990-11-07
DE68912355T2 (de) 1994-08-25
EP0326173A2 (en) 1989-08-02
DE68912355D1 (de) 1994-03-03
US4954641A (en) 1990-09-04
EP0326173B1 (en) 1994-01-19
JPH0427237B2 (enExample) 1992-05-11

Similar Documents

Publication Publication Date Title
JPH0574595B2 (enExample)
JPH01193265A (ja) 新規抗腫瘍性抗生物質ｓｆ２５８７物質及びその製造法
JP2594167B2 (ja) 新規抗生物質ｓｆ２６９８物質およびその製造法
JPH01112988A (ja) 新規物質ｄｃ―１０７
JPH06234784A (ja) 新規抗生物質ｓｆ２７６８物質及びその製造法
JP2594085B2 (ja) 新規抗腫瘍抗生物質ｓｆ２５７５物質ならびにその製造法
JPS62294676A (ja) パチュロリドおよびその製造法
JPH05117298A (ja) デプシペプチドａ、ｂその製造方法、並びに抗ウイルス剤及び抗菌剤
JPH01139590A (ja) 新規抗生物質ｓｆ２５８２ａ物質およびｂ物質ならびにそれらの製造法
JP5036554B2 (ja) 新規ステンフォン（ｓｔｅｍｐｈｏｎｅ）類の化合物及びその製造法
JP4221098B2 (ja) 新規抗生物質メレオライドｋ、ｌおよびｍとその製造方法
KR950004181B1 (ko) 항생물질 버미스포린, 그의 제조방법 및 그것을 활성 항균제로서 포함하는 약제 조성물
EP0234431A2 (en) 5-Hydroxydihydrofusarubin, a process for its preparation and its use for the preparation of a medicament
JPS6348284A (ja) 新抗生物質ｙｐ−０２９０８ｌ−ａおよびその製造法
JPWO2006095444A1 (ja) ステンフォン（ｓｔｅｍｐｈｏｎｅ）類およびそれらの製造方法
JPS6330492A (ja) 新規抗生物質ａ１−ｒ２３９７物質及びその製造法
JPH05155876A (ja) 新規抗生物質Ｍｅｒ−ＡＦ１０３２Ａ 及びＭｅｒ−ＡＦ１０３２Ｂ
JPH0656875A (ja) 新規マクロライド抗生物質ｓｆ２７５７物質及びその製造法
JPH0380160B2 (enExample)
JP2002069075A (ja) 新規生理活性物質ｎｋ３４８９６ｂ、及びその製造法
JPH02233689A (ja) 新規抗生物質ｐｆ１０１５物質ならびにその製造法
JPH0948781A (ja) 新規抗生物質ラクトナマイシンおよびその製造法
JPH01165396A (ja) 新規抗生物質ｓｆ２４４８ａ物質、ｓｆ２４４８ｂ物質及びｓｆ２４４８ｃ物質ならびにそれらの製造法
JP2001055386A (ja) 抗生物質ツベラクトマイシンｂ、ｄおよびｅとその製造法
JPH0531552B2 (enExample)